Mallinckrodt to Provide Fiscal 2014 Guidance
Company will hold conference call on Wednesday October 16
DUBLIN--(BUSINESS WIRE)-- Mallinckrodt (MNK) (NYSE: MNK), a leading global specialty pharmaceuticals company, will provide fiscal 2014 financial guidance on October, 16, 2013. The company will hold a conference call for investors beginning at 8:30am/U.S. Eastern Daylight Time. The call can be accessed in three ways.
- At the Mallinckrodt website: http://mallinckrodt.com/investor_relations.aspx
- By telephone: For both listen-only participants and those who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 800-688- 0836. For participants outside the U.S., the dial-in number is 617-614-4072. The access code for all callers is 12188938.
- Through an audio replay: A replay of the call will be available beginning at 12:30pm/ U.S. Eastern Daylight Time on October 16, 2013, and ending at 12:59am/ U.S. Eastern Daylight Time on October 23, 2013. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617- 801-6888. The replay access code for all callers is 51623490.
Mallinckrodt is a leading global specialty pharmaceuticals business that develops, manufactures, markets and distributes specialty pharmaceutical products and medical imaging agents. The companys Specialty Pharmaceuticals segment includes branded and generic drugs, and the Global Medical Imaging segment includes contrast media and nuclear imaging agents. Mallinckrodt has approximately 5,500 employees worldwide. The companys 2012 revenue totaled $2.1 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
John Moten, 314-654-6650
Vice President, Investor Relations
Lynn Phillips, 314-654-3263
Manager, Media Relations
Meredith Fischer, 314-654-6595
Senior Vice President, Communications
Source: MallinckrodtCopyright Business Wire 2013